These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33559991)

  • 1. Getting a Grip on Ki-67.
    Fulton R
    Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):83-85. PubMed ID: 33559991
    [No Abstract]   [Full Text] [Related]  

  • 2. p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: p16/Ki-67 in cervical papanicolaou Tests.
    Atkins K
    Cancer Cytopathol; 2011 Jun; 119(3):145-7. PubMed ID: 21442766
    [No Abstract]   [Full Text] [Related]  

  • 3. UK NEQAS ICC & ISH Ki-67 Data Reveal Differences in Performance of Primary Antibody Clones.
    Parry S; Dowsett M; Dodson A
    Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):86-94. PubMed ID: 33337635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate identification of proliferative index in melanocytic neoplasms with Melan-A/Ki-67 double stain.
    Puri PK; Valdes CL; Burchette JL; Grichnik JM; Turner JW; Selim MA
    J Cutan Pathol; 2010 Sep; 37(9):1010-2. PubMed ID: 20002650
    [No Abstract]   [Full Text] [Related]  

  • 5. Prognostic value of Ki-67 antigen and p53 protein in urinary bladder cancer: immunohistochemical analysis of radical cystectomy specimens.
    Tsuji M; Kojima K; Murakami Y; Kanayama H; Kagawa S
    Br J Urol; 1997 Mar; 79(3):367-72. PubMed ID: 9117215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of proliferation index in neoplasms using different Ki-67 equivalent antibodies.
    Lindboe CF; von der Ohe G; Torp SH
    APMIS; 2003 May; 111(5):567-70. PubMed ID: 12887508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
    Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
    Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-localisation of insulin-like growth factor II and the proliferation marker MIB1 in hepatocellular carcinoma cells.
    Sohda T; Oka Y; Iwata K; Gunn J; Kamimura S; Shijo H; Okumura M; Yun K
    J Clin Pathol; 1997 Feb; 50(2):135-7. PubMed ID: 9155694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi.
    Kucher C; Zhang PJ; Pasha T; Elenitsas R; Wu H; Ming ME; Elder DE; Xu X
    Am J Dermatopathol; 2004 Dec; 26(6):452-7. PubMed ID: 15618925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical study on the prognostic value of the expression of laminin and Ki-67 receptors in advanced gastric cancer].
    de Manzoni G; Guglielmi A; Di Leo A; Tomezzoli A; Laterza E; Bonfiglio M; Biolo S; Tedesco P; Borzellino G
    G Chir; 1998; 19(8-9):323-8. PubMed ID: 9734182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter.
    Kamai T; Takagi K; Asami H; Ito Y; Arai K; Yoshida KI
    BJU Int; 2000 Jul; 86(1):14-9. PubMed ID: 10886076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma.
    Izban KF; Alkan S; Singleton TP; Hsi ED
    Arch Pathol Lab Med; 2000 Oct; 124(10):1457-62. PubMed ID: 11035575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study.
    Ramírez C; Cheng S; Vargas G; Asa SL; Ezzat S; González B; Cabrera L; Guinto G; Mercado M
    J Clin Endocrinol Metab; 2012 May; 97(5):1745-51. PubMed ID: 22419713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Ki-67, galectin-3, fragile histidine triad, and parafibromin in malignant and benign parathyroid tumors.
    Wang O; Wang CY; Shi J; Nie M; Xia WB; Li M; Jiang Y; Guan H; Meng XW; Xing XP
    Chin Med J (Engl); 2012 Aug; 125(16):2895-901. PubMed ID: 22932087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
    Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
    Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MGMT immunoexpression in growth hormone-secreting pituitary adenomas and its correlation with Ki-67 labeling index and cytokeratin distribution pattern.
    Zuhur SS; Tanik C; Karaman Ö; Velet S; Çil E; Öztürk FY; Özkayalar H; Müslüman AM; Altuntaş Y
    Endocrine; 2011 Oct; 40(2):222-7. PubMed ID: 21792693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of p16/Ki-67 immuno-testing for triage of low grade cervical cytology.
    Kisser A; Zechmeister-Koss I
    BJOG; 2015 Jan; 122(1):64-70. PubMed ID: 25208923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p16/Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy.
    Donà MG; Vocaturo A; Giuliani M; Ronchetti L; Rollo F; Pescarmona E; Carosi M; Vocaturo G; Benevolo M
    Gynecol Oncol; 2012 Aug; 126(2):198-202. PubMed ID: 22588180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-67 staining as a means to simplify analysis of tumor cell proliferation.
    Hitchcock CL
    Am J Clin Pathol; 1991 Oct; 96(4):444-6. PubMed ID: 1716412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.